Gallbladder and Biliary Disease

Gallbladder and Biliary Disease News

  • Viking Shares Surge After Fatty Liver Drug Trial Viking Therapeutics Inc's shares more than doubled in value on Tuesday after promising data from a mid-stage trial of its fatty liver drug were seen as topping that from larger rival Madrigal Pharmaceuticals.
  • Filtered Sunlight Shows Promise for Neonatal Hyperbilirubinemia Filtered-sunlight phototherapy (FSPT) is safe, affordable, and no less effective than intensive electric phototherapy (IEPT) to treat moderate-to-severe hyperbilirubinemia in newborns, a non-inferiority trial conducted in Nigeria suggests.

Gallbladder and Biliary Disease Perspective